Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells
- PMID: 2110975
Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells
Abstract
The vasodilating action of nitroglycerin (NTG) is thought to be mediated by its metabolic activation to nitric oxide (NO) in the vascular smooth muscle cell, but the site at which this process occurs has not been defined. To determine which cellular component is primarily responsible for this metabolic activation, subcellular fractions of bovine vascular smooth muscle cells were prepared and incubated with NTG along with cofactors. Time-dependent headspace NO concentrations generated in these preparations were determined directly by chemiluminescence detection. A mathematical model was developed to relate headspace NO with the NO-generating activity in each incubation, correcting for the concurrent processes of NO partitioning between the headspace and the incubation medium, and NO degradation in these two phases. The estimated NO-generating activities from different subcellular fractions were well correlated with the activities of two enzyme markers of the plasma membrane (K(+)-activated ouabain sensitive p-nitrophenyl phosphatase and 5'-nucleotidase), but not with those of the mitochondria, endoplasmic reticulum or the cytosol. These results indicate that the enzyme(s) responsible for the metabolic activation of NTG, and possibly other organic nitrate vasodilators, are associated with the plasma membrane in bovine coronary smooth muscle cells.
Similar articles
-
Vascular nitric oxide-generating activities for organic nitrites and organic nitrates are distinct.J Pharmacol Exp Ther. 1991 Nov;259(2):519-25. J Pharmacol Exp Ther. 1991. PMID: 1682477
-
Conversion of nitroglycerin to nitric oxide in microsomes of the bovine coronary artery smooth muscle is not primarily mediated by glutathione-S-transferases.J Pharmacol Exp Ther. 1992 Feb;260(2):652-9. J Pharmacol Exp Ther. 1992. PMID: 1738115
-
Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle.J Pharmacol Exp Ther. 1992 Sep;262(3):916-22. J Pharmacol Exp Ther. 1992. PMID: 1527732
-
Nitrite ion is not an active intermediate in the vascular metabolism of organic nitrates and organic nitrites to nitric oxide.Drug Metab Dispos. 1993 Sep-Oct;21(5):967-9. Drug Metab Dispos. 1993. PMID: 7902265 No abstract available.
-
Nitric oxide generation from pharmacological nitric oxide donors.Methods Enzymol. 1996;268:259-65. doi: 10.1016/s0076-6879(96)68028-8. Methods Enzymol. 1996. PMID: 8782592 Review. No abstract available.
Cited by
-
Reduced vascular reactivity after chronic nitroglycerine administration: EDHF mechanism is also downregulated.Br J Pharmacol. 2005 Oct;146(4):479-80. doi: 10.1038/sj.bjp.0706364. Br J Pharmacol. 2005. PMID: 16056231 Free PMC article. No abstract available.
-
Conversion of glyceryl trinitrate to nitric oxide in tolerant and non-tolerant smooth muscle and endothelial cells.Br J Pharmacol. 1993 Jan;108(1):162-9. doi: 10.1111/j.1476-5381.1993.tb13457.x. Br J Pharmacol. 1993. PMID: 8381319 Free PMC article.
-
Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle.Br J Pharmacol. 1995 Jul;115(5):723-32. doi: 10.1111/j.1476-5381.1995.tb14993.x. Br J Pharmacol. 1995. PMID: 8548169 Free PMC article.
-
Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.Br J Pharmacol. 1993 Nov;110(3):937-42. doi: 10.1111/j.1476-5381.1993.tb13903.x. Br J Pharmacol. 1993. PMID: 8298817 Free PMC article.
-
Mechanisms of nitrate tolerance.Cardiovasc Drugs Ther. 1994 Jun;8(3):489-99. doi: 10.1007/BF00877927. Cardiovasc Drugs Ther. 1994. PMID: 7947366 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials